Cardiovascular Disease. Heart failure , Other cardiac arrhythmias, Ischaemic heart diseases, Atrial fibrillation and flutter,
Conditions
Interventions
Intervention 1: Using a program which is including: supportive presence, ritual support and the supportive systems during 3 consecutive days and using Templer Death anxiety Questionnaire in the first
Prevention
Treatment - Drugs
Using a program which is including: supportive presence, ritual support and the supportive systems during 3 consecutive days and using Templer Death anxiety Questionnaire in the first and third day
No intervention in Control Group
Sponsors
Qazvin University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: Suffering from cardiac disease approved by a cardiologist ;No mental retardation, blindness, deafness or any history of mental disease ;Willingness to participate and cooperate in the study ;Ability to communicate ;Conscious and aware of the disease ;Be Muslims ;Persian language speaker exclusion criteria: Non-Muslims ;Suffering from acute ischemic heart disease
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Death Anxiety. Timepoint: During 3 consecutive days. Method of measurement: Templer Death Anxiety Questionnare. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyedeh Hedyeh Banihashemi
Nursing Department
Outcome results
None listed